Product details
Catalog number BNUM0697-50
Price for BNUM0697-50
Size / count 1x 50 µL
Recognizes a protein of 14-16 kDa, which is a novel nuclear antigen of proliferating cells. IPO-38 antigen is present in the nuclei of proliferating cells such as Hodgkin's disease and non-Hodgkin's lymphomas, different forms of leukemias, breast and colorectal carcinomas, and PHA-stimulated lymphocytes. It is not expressed in the cells of non-stimulated lymphocytes and granulocytes. IPO-38 may be a useful marker of cell proliferation during monitoring of tumor progression. This antibody is available purified with BSA/azide at 200 ug/mL, or BSA/azide-free at 1 mg/mL.
The catalog number for IPO-38 (IPO-38), 1mg/mL is BNUM0697-50.
IPO-38 (IPO-38), 1mg/mL is available in the following size(s): 1x 50 µL.
IPO-38 (IPO-38), 1mg/mL is currently made to order / not held in immediate stock. Contact us for lead time.
IPO-38 (IPO-38), 1mg/mL is manufactured by Biotium.
Estimated delivery time for IPO-38 (IPO-38), 1mg/mL is approximately 15 business day(s), depending on your location.
The safety data sheet for IPO-38 (IPO-38), 1mg/mL is available here: https://cdn.gentaur.com/products/37/68dd029d061270361e102897/msds/bnum0697-50.pdf.
Recognizes a protein of 14-16 kDa, which is a novel nuclear antigen of proliferating cells. IPO-38 antigen is present in the nuclei of proliferating cells such as Hodgkin's disease and non-Hodgkin's lymphomas, different forms of leukemias, breast and colorectal carcinomas, and PHA-stimulated lymphoc
Yes, contact us with details of your sample type, species, and intended application, and our specialists will confirm suitability or suggest an alternative from our supplier network if this isn’t the best fit.
Purity, typically assessed by SDS-PAGE, is listed on the datasheet under quality control data.
Report this to us immediately with photos and your order reference. Our specialists will assess whether the product is still usable given the cold-chain interruption, and will arrange a replacement or credit if it isn’t.